RMT Provides Significant ROI with Enhanced Telecytology Workflows
Remote Medical Technologies’ (RMT) was honored to demonstrate our Telecytology Solution at the 2018 conference in Washington, DC.
Industry leaders articulated the proven benefits and ROI of the RMT Telecytology Solution. The RMT Family is grateful and privileged to have been selected for the innovative programs that these cytology experts have designed for daily use.
Proven studies show that cytopathologists have saved over 86% of their time by implementing RMT Telecytology for ROSE!
RMT cleverly combined their telepathology technology with a purpose-built mobile cart, accommodating industrial-strength wireless connectivity, for rapid on-site evaluations.
Generate NEW Revenue Flows- ROSE is clinically useful and a billable procedure!